EcoDrugPlus

Casein Kinase 2 Alpha 1

Ensembl ID : ENSBMUG00000015893
Gene Symbol: CSNK2A1
2 Cross references
138 Possible Orthologues:

Caspase 8

Ensembl ID : ENSBMUG00000016946
Gene Symbol: CASP8
3 Cross references
132 Possible Orthologues:

Caspase 9

Ensembl ID : ENSBMUG00000025595
Gene Symbol: CASP9
3 Cross references
204 Possible Orthologues:

Catechol-O-Methyltransferase

Ensembl ID : ENSBMUG00000004884
Gene Symbol: COMT
2 Cross references
277 Possible Orthologues:

Cathepsin C

Ensembl ID : ENSBMUG00000026325
Gene Symbol: CTSC
3 Cross references
235 Possible Orthologues:

Cathepsin K

Ensembl ID : ENSBMUG00000023829
Gene Symbol: CTSK
3 Cross references
246 Possible Orthologues:

Cathepsin S

Ensembl ID : ENSBMUG00000023817
Gene Symbol: CTSS
3 Cross references
270 Possible Orthologues:

Cell Division Cycle 7

Ensembl ID : ENSBMUG00000014193
Gene Symbol: CDC7
3 Cross references
209 Possible Orthologues:

Checkpoint Kinase 1

Ensembl ID : ENSBMUG00000022949
Gene Symbol: CHEK1
3 Cross references
179 Possible Orthologues:

Checkpoint Kinase 2

Ensembl ID : ENSBMUG00000026548
Gene Symbol: CHEK2
3 Cross references
206 Possible Orthologues:

Cholecystokinin A Receptor

Ensembl ID : ENSBMUG00000009499
Gene Symbol: CCKAR
3 Cross references
201 Possible Orthologues:

Cholinergic Receptor Muscarinic 1

Ensembl ID : ENSBMUG00000023670
Gene Symbol: CHRM1
3 Cross references
104 Possible Orthologues:

Select Keywords:


PREMIER has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 875508. The JU receives support from the EU’s Horizon 2020 research and innovation programme and the European Federation of Pharmaceutical Industries and Associations (EFPIA). The views reflect only the authors’ perspective and the JU is not responsible for any use that may be made of the information this manuscript contains. Elements of the website have been developed under projects PREMIER and the Biocenter Finland Drug Discovery and Chemical Biology network. CSC-IT is thanked for providing computational resources. Content of the website is provided without guarantee for correctness. Data has been collected and integrated from multiple public sources, for the largest: FDA, HUGO Gene Nomenclature Committee, ChEMBL, IUPHAR/BPS guide to pharmacology, Reactome, UniProt, and Ensembl. Credit is given to Ensembl for collecting species images (provided under public domain licences such as Wikimedia and NHGRI).

PREMIER has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 875508. The JU receives support from the EU’s Horizon 2020 research and innovation programme and the European Federation of Pharmaceutical Industries and Associations (EFPIA). The views reflect only the authors’ perspective and the JU is not responsible for any use that may be made of the information this manuscript contains.

Elements of the website have been developed under projects PREMIER and the Biocenter Finland Drug Discovery and Chemical Biology network. CSC-IT is thanked for providing computational resources. Content of the website is provided without guarantee for correctness. Data has been collected and integrated from multiple public sources, for the largest: FDA, HUGO Gene Nomenclature Committee, ChEMBL, IUPHAR/BPS guide to pharmacology, Reactome, UniProt, and Ensembl. Credit is given to Ensembl for collecting species images (provided under public domain licences such as Wikimedia and NHGRI).